指南与共识泌尿生殖腹部MR

前列腺复发报告影像解读:用户指南

Prostate Imaging for Recurrence Reporting: User Guide.
PubMed 文献 · Radiographics · 2025-01-01

本文介绍2021年提出的前列腺复发报告影像系统(PI-RR),该系统用于标准化全腺体治疗(根治性前列腺切除术或放疗)后盆腔MRI的操作与解读。文中讨论PI-RR的理论依据、技术标准与报告指南,回顾放疗和根治性前列腺切除术后MRI的评分系统,通过教学病例说明PI-RR的使用,并描述初步实施中的陷阱和未来发展领域。

要点

  • PI-RR用于标准化全腺体治疗后可疑复发前列腺癌的MRI报告。
  • 治疗后重点转向动态对比增强(DCE)成像检测复发。
  • DCE局灶早期强化及程度较轻的明显弥散受限是复发的关键MRI表现。

核心结论

  • PI-RR系统旨在为不同经验水平的前列腺MRI阅片者提供综合参考,以标准化可疑复发前列腺癌的报告。

研究设计与样本

  • 本文为PI-RR用户指南,讨论其理论依据、技术标准和报告指南,并通过教学病例说明其使用。
  • PI-RR于2021年提出,用于标准化全腺体治疗(根治性前列腺切除术或放疗)后盆腔MRI的操作与解读。
  • PI-RR使用与PI-RADS第2.1版相似的命名,系统化编码评分要素。

关键影像表现/征象

  • DCE图像上的局灶早期强化,以及程度较轻的明显弥散受限,是根治性前列腺切除术和放疗后复发的关键MRI表现。
  • PI-RADS中强调T2加权和弥散加权成像用于癌症检测,而治疗后PI-RR的重点转向DCE成像检测复发。

诊断标准与关键数值

  • PI-RR评分系统分别针对放疗后和根治性前列腺切除术后MRI,涵盖两种场景下相关的T2加权、弥散加权和DCE特征。
  • PI-RR使用与PI-RADS第2.1版相似的命名,系统化编码评分要素。

临床应用与阅片要点

  • 治疗后评估中应重视DCE成像,局灶早期强化是提示复发的关键征象。
  • 解读PI-RR时需注意将其与PI-RADS区分,两者在治疗后评估中的解读差异显著。
  • 初步实施PI-RR时存在陷阱,需关注文中描述的相关内容。

局限性

  • 原文描述了初步实施PI-RR中的陷阱和未来发展领域。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

The Prostate Imaging for Recurrence Reporting (PI-RR) system was introduced in 2021 to standardize the performance and interpretation of pelvic MRI after whole-gland treatment with radical prostatectomy (RP) or radiation therapy (RT). The Prostate Imaging Reporting and Data System (PI-RADS) defines technical and reporting standards for imaging prostate cancer before treatment. Although similar imaging techniques can be applied in assessing the treated prostate gland, the interpretation varies substantially between PI-RADS and PI-RR. With PI-RADS, T2-weighted and diffusion-weighted imaging are emphasized for cancer detection. After treatment, the emphasis shifts in PI-RR to detect recurrence with dynamic contrast enhancement (DCE) imaging. Focal early enhancement on DCE images, and to a lesser degree marked diffusion restriction, are the key MRI findings of recurrence after RP and RT. Using nomenclature similar to that of PI-RADS version 2.1, PI-RR uses established knowledge of recurrent prostate cancer MRI features and systematically codifies scoring elements. The authors discuss the PI-RR rationale, technical standards, and reporting guidelines. The scoring system for posttreatment MRI after RT and RP is reviewed, exploring the relevant T2-weighted, diffusion-weighted, and DCE features for both scenarios. The use of PI-RR is illustrated through instructive cases. Finally, pitfalls in the initial implementation of PI-RR and areas for future development are described. The goal is to provide a comprehensive reference for prostate MRI readers of all experience levels to use PI-RR in standardizing reporting of suspected recurrent prostate cancer. ©RSNA, 2025 See the invited commentary by Dias and Haider in this issue.

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Shetty AS, Fraum TJ, Ippolito JE, et al. Prostate Imaging for Recurrence Reporting: User Guide. Radiographics. 2025. PMID: 40742877. doi:10.1148/rg.240145

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。